Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam
· Delayed Price · Currency is VND 71,000
+1,000 (1.43%)
At close: Apr 28, 2026
Ha Tay Pharmaceutical JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 6,430,757 | 6,340,200 | 7,822,325 | 1,893,826 | 1,027,245 | 1,188,329 | Upgrade
|
| Market Cap Growth | -3.46% | -18.95% | 313.04% | 84.36% | -13.56% | 5.54% | Upgrade
|
| Enterprise Value | 6,558,013 | 6,536,629 | 7,994,725 | 2,176,376 | 1,106,314 | 1,060,741 | Upgrade
|
| Last Close Price | 71000.00 | 70000.00 | 86363.64 | 20336.49 | 12284.00 | 13536.16 | Upgrade
|
| PE Ratio | 110.06 | 118.16 | 108.99 | 22.27 | 10.79 | 17.49 | Upgrade
|
| PS Ratio | 2.68 | 2.64 | 3.75 | 0.95 | 0.56 | 0.74 | Upgrade
|
| PB Ratio | 5.79 | 5.71 | 7.40 | 1.78 | 1.29 | 1.58 | Upgrade
|
| P/TBV Ratio | 5.95 | 5.86 | 7.61 | 1.83 | 1.33 | 1.63 | Upgrade
|
| P/FCF Ratio | 36.34 | 35.83 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 28.49 | 28.09 | 279.78 | 6.99 | - | - | Upgrade
|
| EV/Sales Ratio | 2.73 | 2.72 | 3.83 | 1.09 | 0.60 | 0.66 | Upgrade
|
| EV/EBITDA Ratio | 90.78 | 100.79 | 82.43 | 18.71 | 9.24 | 13.48 | Upgrade
|
| EV/EBIT Ratio | 136.34 | 160.56 | 104.49 | 21.94 | 10.80 | 17.09 | Upgrade
|
| EV/FCF Ratio | 37.06 | 36.94 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.30 | 0.45 | 0.47 | 0.42 | 0.38 | Upgrade
|
| Debt / EBITDA Ratio | 5.14 | 5.14 | 4.85 | 4.33 | 2.81 | 3.68 | Upgrade
|
| Debt / FCF Ratio | 1.88 | 1.88 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.09 | 0.09 | 0.27 | 0.11 | 0.23 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.52 | 1.52 | 2.99 | 1.05 | 1.54 | -1.69 | Upgrade
|
| Net Debt / FCF Ratio | 0.56 | 0.56 | -2.52 | -1.27 | -0.64 | 1.59 | Upgrade
|
| Asset Turnover | 1.25 | 1.25 | 1.11 | 1.21 | 1.36 | 1.49 | Upgrade
|
| Inventory Turnover | 4.21 | 4.21 | 4.12 | 4.28 | 4.12 | 4.08 | Upgrade
|
| Quick Ratio | 0.47 | 0.47 | 0.40 | 0.81 | 0.47 | 1.18 | Upgrade
|
| Current Ratio | 1.22 | 1.22 | 1.21 | 1.69 | 1.80 | 2.10 | Upgrade
|
| Return on Equity (ROE) | 5.45% | 5.45% | 7.08% | 9.54% | 12.75% | 12.95% | Upgrade
|
| Return on Assets (ROA) | 1.32% | 1.32% | 2.54% | 3.75% | 4.73% | 3.60% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.64% | 2.56% | 4.76% | 7.37% | 10.27% | 9.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.40% | 3.40% | 6.60% | 8.00% | 11.30% | 8.20% | Upgrade
|
| Earnings Yield | 0.83% | 0.85% | 0.92% | 4.49% | 9.27% | 5.72% | Upgrade
|
| FCF Yield | 2.75% | 2.79% | -1.47% | -5.05% | -27.84% | -7.05% | Upgrade
|
| Dividend Yield | - | - | - | - | 2.64% | 2.40% | Upgrade
|
| Payout Ratio | - | - | 111.73% | - | 53.87% | 29.96% | Upgrade
|
| Buyback Yield / Dilution | 8.17% | 8.17% | -62.83% | 31.61% | -0.77% | 0.77% | Upgrade
|
| Total Shareholder Return | 8.17% | 8.17% | -62.83% | 31.61% | 1.87% | 3.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.